Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions focus on the key findings of the study—particularly that higher doses of psilocybin induce significant mystical experiences—and express curiosity about the implications for therapy and wellbeing. The tone varies from supportive to interested, with examples like mentioning the doses (20-30 mg) and referencing the study’s potential influence on psychedelics research, illustrating a blend of acknowledgment and curiosity about future applications.
Most discussions acknowledge the study's findings on dose-related mystical experiences, indicating general support or acceptance of the research results.
The discussions reflect high interest, with multiple mentions of the study's details, implications, and potential therapeutic benefits.
Participants reference specific studies, doses, and subjective effects, showing active engagement but not deep scientific critique.
While there's acknowledgment of the research's importance, the impact perception is moderate, emphasizing potential but not suggesting transformative societal changes.
In the 2011 Johns Hopkins study (link below) where they looked at different doses of pure psilocybin, they found that the two highest doses (20 and 30 mg psilocybin per 1 kg of body weight) induced "mystical-type experiences" in most people. 5/ https://t.co/zscLU2kcXZ
@PaulAustin3w @thirdwaveishere In a 2011 study by Johns Hopkins, "Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects" on doses ranging from 5 to 30 mg of ps, it was found that 20mg had the highest benefits with lowest challenges.
A 2011 Johns Hopkins study by @Drug_Researcher and co (link below) looked at different doses of #psilocybin. They found that the two highest doses (20 and 30 mg psilocybin per 70 kg body weight) induced "mystical-type experiences" in most people. 5/ https://t.co/wO4jL5o93Q
Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects: https://t.co/FFsBScHjmn #psilocybin #psilocybinresearch #psychedelics
@DevWallace1 https://t.co/u7VTuBFICd Use this article to get the paper if you can't access it: https://t.co/zPZD9YcMvi
@DrCMBurritt @CLOSLER @JHPsychedelics @N_Gukasyan @drjanaway @michaelpollan I see evidence for some real risk of adverse effects - but "immense destruction"? No - that statement doesn't appear to be grounded in the available evidence... https://t.co/iIPFIMzmaR https://t.co/Mu61Clc2Aw https://t.co/ZcULnDCSzd https://t.co/T8xnOMGj9V https://t.co/1ef1pGCyNr
Mckenna discusses primate dominance hierarchies and mankind's materialistic culture. He explores how psilocybin may have influenced human prehistory and its potential future applications, emphasizing its capacity to…
Research shows that mystical experiences induced by psilocybin predict long-term personal and spiritual growth, positively impacting well-being and life satisfaction. This video explores how these profound experiences…
@PaulAustin3w @thirdwaveishere In a 2011 study by Johns Hopkins, "Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects" on doses ranging from 5 to 30 mg of ps, it was found that 20mg had the highest benefits with lowest challenges.
@myRed_5 @rogerplunk @N_Gukasyan https://t.co/fLiZ8vN4iV
@MichaelDPlant ...there's also all sorts of subjective changes ppts report, but that sounds like the sort of thing you're aware of already. imho good quality research is pretty sparse at this point, but due to lack of evidence, not failed attempts to find evidence https://t.co/93tBg8Ajyg
@DrCMBurritt @CLOSLER @JHPsychedelics @N_Gukasyan @drjanaway @michaelpollan I see evidence for some real risk of adverse effects - but "immense destruction"? No - that statement doesn't appear to be grounded in the available evidence... https://t.co/iIPFIMzmaR https://t.co/Mu61Clc2Aw https://t.co/ZcULnDCSzd https://t.co/T8xnOMGj9V https://t.co/1ef1pGCyNr
In some of the pioneering psilocybin studies (https://t.co/7Y4svMU5D3) done at Johns Hopkins University, controlled doses of psilocybin were administered to patients.
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects [Roland R. Griffiths, Matthew W. Johnson, et al. Psychopharmacology volume 218, pages649–665 (2011)] https://t.co/GEcA8VDxHT https://t.co/EtcJxV43YS
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects [Roland R Griffiths, Matthew W Johnson, et al. Psychopharmacology (Berl). 2011 Dec;218(4):649-65. doi: 10.1007/s00213-011-2358-5.] https://t.co/v9kQfqnljd
@DevWallace1 https://t.co/u7VTuBFICd Use this article to get the paper if you can't access it: https://t.co/zPZD9YcMvi
RT @trikomes: A 2011 Johns Hopkins study by @Drug_Researcher and co (link below) looked at different doses of #psilocybin. They found tha…
A 2011 Johns Hopkins study by @Drug_Researcher and co (link below) looked at different doses of #psilocybin. They found that the two highest doses (20 and 30 mg psilocybin per 70 kg body weight) induced "mystical-type experiences" in most people. 5/ https://t.co/wO4jL5o93Q
Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects: https://t.co/FFsBScHjmn #psilocybin #psilocybinresearch #psychedelics
RT @trikomes: In the 2011 Johns Hopkins study (link below) where they looked at different doses of pure psilocybin, they found that the two…
In the 2011 Johns Hopkins study (link below) where they looked at different doses of pure psilocybin, they found that the two highest doses (20 and 30 mg psilocybin per 1 kg of body weight) induced "mystical-type experiences" in most people. 5/ https://t.co/zscLU2kcXZ
Psychopharmacology 218 (4), 649–665. https://doi.org/ 10.4135/9781849200462.n13. 10.1007/s00213- 011-2358-5. Michl, L.C., McLaughlin, K.A. ...
... 10.1007/s00213-011-2358-5 dysfunction in posttraumatic stress disorder : From mouse to man. [37] MacLean, K.A.; Johnson, M.W.; Griffiths, R.R. Mystical ...
doi: 10.1007/s00213-011-2358-5. Epub 2011 Jun 15. RECREATIONAL CHAMPION We chose this champion based on having a total tryptamine content at around 10mg/g ...
doi: 10.1007/s00213-011-2358-5 24. Carryer JR, Greenberg LS. Optimal levels of emotional arousal in 9. Studerus E, Gamma A, Kometer M, Vollenweider FX ...
doi: 10.1007/s00213-011-2358-5. Epub 2011 Jun 15. PMID: Decriminalize Nature Michigan & Oakland Hyphae Present the Michigan Psilocybin Cup Spectrum Report ...
doi:10.1007/s00213-011-2358-5. PMC 3308357 Freely accessible . PMID 21674151. Lay summary – Newswise.com (2011-06-13). ^ Jump up to: Hillebrand J ...
https://doi.org/10.1007/s00213-011-2358-5 #psilocybin #research #science #magicmushrooms #depression #therapy #health #علم · #درمان #افسردگی.
https://doi.org/10.1007/s00213-011-2358-5 #psilocybin #research #science #magicmushrooms #depression #therapy #health #علم · #درمان #افسردگی.
com/content/pdf/10.1007/s00213-011-2358-5. pdf 3. Magic mushroom use: A qualitative interview study of post-trip impacts and strategies for ...
com/content/pdf/10.1007/s00213-011-2358-5.pdf 3. Magic mushroom use: A qualitative interview study of post-trip impacts and strategies for ...
doi:10.1007/s00213-011-2358-5. Krems, J. A., Kenrick, D. T., & Neel, R. (2017). Individual Perceptions of Self-Actualization: What Functional ...
10.1007/s00213-011-2358-5 [PMC free article] [PubMed] [Cross Ref] Grimble R. F. (1994). Nutritional antioxidants and the modulation of ...
doi: 10.1007/s00213-011-2358-5. Klavetter, R. E., & Mogar, R. E. (1967). Peak Experiences: Investigation of Their Relationship to Psychedelic ...
http://link.springer.com/10.1007/s00213-011-2358-5, accessed February 13, 2015. Griffiths, R., W. Richards, M. Johnson, U. McCann, and R ...
doi: 10.1007/s00213-011-2358-5. Griffiths, R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008). Mystical-type experiences ...
doi: 10.1007/s00213-011-2358-5. Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type ...
NJ
RP
SS
DY
T
BS
CC
A